483 Eli Lilly & Company Apr 2013

483 Eli Lilly & Company Apr 2013

Thomas Arista FDA, Robert Barbosa FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 19 Apr 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Apr 2013
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart